This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Relay Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Aaron Dumas: Innovator in FGFR Inhibitors
Introduction
Aaron Dumas is a notable inventor based in Hertfordshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of FGFR inhibitors. His work focuses on innovative methods of making and using these compounds, which have potential therapeutic applications.
Latest Patents
Dumas holds a patent for "FGFR inhibitors and methods of making and using the same." This patent is directed to crystalline forms of N-(4-(4-amino-5-(3-fluoro-4-((4-methylpyrimidin-2-yl)oxy)phenyl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl)methacrylamide. The patent also covers its salts, cocrystals, and variants thereof. He has 1 patent to his name.
Career Highlights
Dumas is currently associated with Relay Therapeutics, Inc., where he continues to push the boundaries of drug discovery and development. His expertise in FGFR inhibitors positions him as a key player in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include André Lescarbeau and Jethro Beamish-Cook. Their collaborative efforts contribute to the innovative environment at Relay Therapeutics.
Conclusion
Aaron Dumas is a prominent inventor whose work on FGFR inhibitors showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic options in the pharmaceutical landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile